TGA Approval

BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler (385649)

ARTG ID

385649

ARTG Name

BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler

Sponsor

Grand Medical Pty Ltd

ARTG Date

July 7, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Grand Medical Pty Ltd

Sponsor Item Name

GRAND MEDICAL PTY LTD.

Active Ingredients

Ingredient Name

indacaterol acetate

Ingredient Name

mometasone furoate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler (385649) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

BEMRIST BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler (385649)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal